Narrative review / 2009
Cyanobacterial BMAA bioaccumulates in food chains and is detected in brains of patients with ALS, Alzheimer's disease, and Guamanian ALS/PDC.
This review discusses the hypothesis that the neurotoxin beta-methylamino-L-alanine (BMAA), produced by cyanobacteria, may contribute to ALS and other neurodegenerative diseases. Protein-bound BMAA was identified in brains of Guamanians dying of ALS/PDC (average 627 microg/g, 5 mM) and North American Alzheimer's disease patients (average 95 microg/g, 0.8 mM), but not in controls. Although Montine et al. failed to replicate these findings using different methods, subsequent work confirmed protein-bound BMAA (>100 microg/g) in brains of North American patients dying with ALS and Alzheimer's disease.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review / hypothesis paper
- Who was studied
- Human brain tissues (Guam ALS/PDC cases, North American ALS and AD patients, controls)
- What was measured
- Detection of BMAA in brain tissues and food chain
THE PAPER
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG, Mash DC. Amyotroph Lateral Scler, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.